<?xml version="1.0" encoding="utf-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd"><url><loc>https://www.pharmamanufacturing.com/industry-news/news/55376210/prolific-machines-reports-21-g-l-antibody-titer-in-intensified-fed-batch-cho-run</loc><news:news><news:publication><news:name>Pharma Manufacturing</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-08T14:20:00.000Z</news:publication_date><news:title>Prolific Machines reports 21 g/L antibody titer in intensified fed-batch CHO run</news:title></news:news></url><url><loc>https://www.pharmamanufacturing.com/industry-news/news/55376204/hovione-idc-open-intranasal-drug-delivery-platform-for-commercial-partnerships</loc><news:news><news:publication><news:name>Pharma Manufacturing</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-08T14:16:23.849Z</news:publication_date><news:title>Hovione, IDC open intranasal drug delivery platform for commercial partnerships</news:title></news:news></url></urlset>